| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad156e78e3e5cdb0fe86af95bb427908
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9935a32b08c69d1748f15165a1986b48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate |
2015-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd2f8abf398b03c76c8b28a3eb114235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3251ee57456f198ccb5da358083cb1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e79595ca6f85dd87bda239650baf3660
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99c47c8d91e5a2a0367bf3b9293fb5e5 |
| publicationDate |
2017-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017082760-A1 |
| titleOfInvention |
{3-[4-(7h-pyrrolo[2,3-d] pyrimidin-4-yl)-pyrazol-1-yl]-1-ethylsulphonyl-azetidin-3-yl}-acetonitrile dichloroacetate as a janus kinase inhibitor |
| abstract |
The aim of the invention is to create a novel JAK inhibitor for treating rheumatoid arthritis, cancer and other diseases. This is achieved with {3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-pyrazol-1-yl]-1-ethylsulphonyl-azetidin-3-yl}-acetonitrile dichloroacetate of formula 1, or the solvates thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10766900-B2 |
| priorityDate |
2015-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |